Hermida PJA, Buduen NA, Capote LL

Language: Spanish
References: 12
Page: 646-651
PDF size: 453.69 Kb.

ABSTRACT

Background: lung cancer is the most common cause of cancer mortality worldwide. It is one of the cancers with worse prognosis, since it is usually diagnosed in advanced stages. Early detection, in the pulmonary nodule phase, would allow an earlier therapeutic intervention, improving prognosis and survival. Important diagnostic tools include chest radiography, computed tomography, fine needle aspiration, and a large number of differential diagnoses including benign and malignant lesions. Objective: to describe the clinical, radiological, histopathological and differential diagnoses of the solitary pulmonary nodule of subpleural location. Clinical case: a clinical case with a solitary pulmonary nodule and initial presumptive diagnosis of lung carcinoma is described; after being studied and performed lung lobectomy, diagnosed as an inflammatory cause, pneumonia. Conclusions: 95 % of solitary pulmonary nodules are neoplasias secondary to conditions with which a differential diagnosis can be established. The most frequent cause is granulomas secondary to infectious inflammatory conditions, following in order of frequency the cancer and within them the bronchogenic carcinoma.

REFERENCES

1. 1.Arias OD, Armas Pérez B de, Gil Hernández A, Gordis Aguilera MV. Nódulo pulmonar solitario. ¿Qué hacer? Rev Cubana Cir. 2007;46(2):34-42.

2. 2.Fletcher JW. PET scanning and the solitary pulmonary nodule. Semin Thorac Cardiovasc Surg. 2002;14:268-74.

3. 3.Hartman TE. Radiologic evaluation of the solitary pulmonary nodule. Semin Thorac Cardiovasc Surg. 2002;14:261-7.

4. 4.Divisi D, Barone M, Zaccagna G, Crisci R.Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography in the Management of Solitary Pulmonary Nodule: A Review. Ann Med. 2017 Jun 7:1-24.

5. 5.Silvestri GA, Vachani A, Whitney D, Elashoff M, Smith KP, Ferguson JS, et al. A Bronchial Genomic Classifier for the Diagnostic Evaluation of Lung Cancer. N Engl J Med. 2015;373:243-251.

6. 6.Moreno Balsalobre R, Fernández Fau L. Nódulo pulmonar solitario: ¿qué ha cambiado en su evaluación diagnóstica? Arch Bronconeumol. 2003;39:246-248.

7. 7.Bacalja J, Nikolic I, Brcic L. Lipoma pulmonar intraparenquimatos con comportamiento clínico de neoplasia maligna. Arch Bronconeumol. 2015;51:302-3.

8. 8.Dabó H, Marinho A, Gomes I. Aspergilosis pulmonar nodular,¿todavía supone un desafío? Arch Bronconeumol. 2015;51:603-4.

9. Sileli M, Tsagkaropoulos S, Madesis A. Dirofilariasis pulmonar: un reto diagnóstico en la práctica clínica. Arch Bronconeumol. 2016;52:338-9.

10. 10.Pérez-Ferrer P, Chiner E, Sancho-Chust JN, Arlandis M. Leiomiomatosis pulmonar benigna metastatizante, una causa excepcional de nódulos pulmonares. Arch Bronconeumol. 2016;52:226-7.

11. 11.Orta R, Paganini L, Davies KM, Dalurzo ML, Ulla M, García Mónaco R. Nódulos pulmonares subsólidos en tomografía computada multicorte. Características y diagnósticos diferenciales con el adenocarcinoma de pulmón. RAR. 2013;77(2):107-117.

12. 12.Yang L, Zhang Q, Bai L, Li TY, He C, Ma QL, et al. Assessment of the cancer risk factors of solitary pulmonary nodules. Oncotarget. 2017 Apr 25;8(17):29318-29327.